Antisnake Venom Production Crisis—Who Told Us It Was Uneconomic and Unsustainable?
- 1 June 2009
- journal article
- research article
- Published by SAGE Publications in Wilderness & Environmental Medicine
- Vol. 20 (2), 144-155
- https://doi.org/10.1580/08-weme-con-273r1.1
Abstract
The world of antisnake venom production is currently a gloomy place to visit. It is described as being in crisis, characterized by shortages, producers leaving the market, high prices, and unsustainability. It has been reduced to a pauper-like status, doomed to relying on chari\ handouts for resolution. The worrying aspect of this is that little work has been done to establish the true economics and return on antisnake venom if provided by private companies. Fortunately, it is amenable to economic analysis, and in this manner, a rational approach to further development and distribution can be obtained. This article proposes a model antisnake venom (ASV) production unit and shows the likely economics and return based on the production of various volumes of ASV. It estimates the costs for the key components of the unit, which are production equipment and staffing. A profit and loss account and balance sheet are constructed for the unit, and the effects of ASV volume and neutralizing titres are demonstrated. It is our contention that ASV production can be sustained at affordable prices in the developing world. We recommend that any solution to the ASV shortage must take into account the most cost efficient method(s) of production.Keywords
This publication has 29 references indexed in Scilit:
- The Global Snakebite Crisis—A Public Health Issue Misunderstood, Not NeglectedWilderness & Environmental Medicine, 2009
- Time for an Alternative Perspective: The Eternal Problem of Supply and Quality of Anti Snake Venom in the Developing World—“It's the Economy, Stupid”Wilderness & Environmental Medicine, 2008
- Strengthening antivenom production in Central and South American public laboratories: Report of a workshopToxicon, 2007
- Confronting the Neglected Problem of Snake Bite Envenoming: The Need for a Global PartnershipPLoS Medicine, 2006
- Economic evaluation of snake antivenom production in the public systemJournal of Venomous Animals and Toxins including Tropical Diseases, 2006
- Venomous Snakebites Worldwide with a Focus on the Australia-Pacific Region: Current Management and ControversiesJournal of Intensive Care Medicine, 2004
- Clinical Toxinology—Where Are We Now?Journal of Toxicology: Clinical Toxicology, 2003
- A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenomsToxicon, 1999
- Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphateJournal of Immunological Methods, 1990
- A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluidJournal of Immunological Methods, 1987